23.02.2022
Omówienie artykułu: Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
T. Conroy i wsp.
Lancet Oncology, 2021; 22: 702–715